Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
|Videos|June 22, 2015
Changes Ahead for Specialty Pharmacy Patients
Author(s)Davy James, Managing Editor
Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how the specialty pharmacy landscape will evolve in the coming years.
Advertisement
Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how the specialty pharmacy landscape will evolve in the coming years.
This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Advertisement
Related to this article
FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Reframing Statins and Brain Health Around Stroke Prevention
2
Semaglutide Normalized Liver Fat in Most Adults With Obesity
3
Phase 3 Trial Finds Adding Monoclonal Antibody to mRNA Vaccine Improves COVID-19 Immunization Tolerability
4
mRNA Reenters the Mainstream
5